Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
FDA approved a Supplemental Application for Levothyroxine Sodium from Alvogen, Inc. to continue regulatory recognition of the drug under its…
-
FDA approval · 2015-04-15FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) filed by AbbVie, indicating an approved change to the product's…
-
FDA approval · 2015-02-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
The FDA approved a supplemental application for LEVOTHYROXINE SODIUM from Lannett Company, Inc., updating or expanding the labeling for the …
-
FDA approval · 2014-11-05FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) from Pfizer Laboratories Div Pfizer Inc. This action updates …
-
FDA approval · 2014-10-30FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Levothyroxine Sodium from Mylan Pharmaceuticals Inc., approving changes to the existing product …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental ANDA for levothyroxine sodium from Mylan Pharmaceuticals, authorizing the marketing of a generic levothyroxi…
-
FDA approval · 2014-09-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for levothyroxine sodium from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2014-05-27FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, updating the product's labeling under NDA 021402.
-
FDA approval · 2014-05-06FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc. The action repre…
-
FDA approval · 2014-04-08FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, authorizing changes to the drug's labeling.
-
FDA approval · 2013-11-26FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Levothyroxine sodium (levothyroxine sodium anhydrous) from Fresenius Kabi USA, LLC.
-
FDA approval · 2012-12-20FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Levothyroxine Sodium (Levothyroxine Sodium Anhydrous) by Fresenius Kabi USA, LLC.
-
FDA approval · 2012-12-14FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for LEVOXYL (levothyroxine sodium), resulting in labeling updates for its use in hypothyroidi…
-
FDA approval · 2012-11-29FDA Approved: LIOMNY — Original Application (SIGMAPHARM LABORATORIES, LLC)
FDA approved LIOMNY (liothyronine sodium) from SigmaPharm Laboratories as an original abbreviated new drug application (ANDA) for the treatm…
-
FDA approval · 2012-11-20FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved a supplemental application for levothyroxine sodium from Lannett Company, Inc., supporting the generic product's continued mark…
-
FDA approval · 2012-03-04FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) submitted by IBSA Pharma Inc., updating the product labeling…
-
FDA approval · 2011-03-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved the supplemental application for Levothyroxine Sodium from Lannett Company, Inc, authorizing the marketing of this generic prod…
-
FDA approval · 2011-01-14FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for SYNTHROID (levothyroxine sodium) by AbbVie. The approval updates the product under the supplemen…
-
FDA approval · 2009-09-01FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2009-06-14FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved a supplemental application for Levothyroxine Sodium from Lannett Company, Inc., reinforcing the product's existing approval via…
-
FDA approval · 2009-03-20FDA Approved: LIOTHYRONINE SODIUM — Original Application (Dr. Reddy's Labratories Inc.)
FDA approved an original Abbreviated New Drug Application for Liothyronine sodium from Dr. Reddy's Labratories Inc., making a generic thyroi…
-
FDA approval · 2008-10-30FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for levothyroxine sodium from Mylan Pharmaceuticals Inc., granting regulatory approval for this gene…
-
FDA approval · 2008-07-14FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Synthroid (levothyroxine sodium) submitted by AbbVie Inc. The approval relates to changes in…
-
FDA approval · 2008-07-08FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Levoxyl (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc, resulting in…
-
FDA approval · 2008-06-10FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
The FDA approved a supplemental application for levothyroxine sodium submitted by Lannett Company, Inc., authorizing continued marketing of …